Under this agreement, Tabuk Pharmaceuticals will market Biocon’s GLP-1 products across Saudi Arabia and other countries in the Middle East. Shares of Biocon Ltd ended at ₹372.50, up by ₹1.15, or 0.31%, on the BSE.
Under this agreement, Tabuk Pharmaceuticals will market Biocon’s GLP-1 products across Saudi Arabia and other countries in the Middle East. Shares of Biocon Ltd ended at ₹372.50, up by ₹1.15, or 0.31%, on the BSE.